Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

InspireMD, Inc. Director's Dealing 2025

Sep 17, 2025

34187_dirs_2025-09-17_f616bf86-e1e9-4b00-aa32-51f645a47840.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2025-09-15

Reporting Person: Kester Thomas J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-09-15 Common Stock A 37815 Acquired 458573 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-09-15 Options to purchase common stock (right to buy) $2.38 A 19041 Acquired 2027-09-15 Common Stock (19041) Direct

Footnotes

F1: Represent grant of shares of common stock for services rendered as a director of the issuer in 2025 prior to the Reporting Person's resignation as a director, effective September 16, 2025.